Cibc Private Wealth Group, LLC Xeris Biopharma Holdings, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 6,664 shares of XERS stock, worth $66,373. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,664
Previous 6,664
-0.0%
Holding current value
$66,373
Previous $22,000
63.64%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding XERS
# of Institutions
217Shares Held
89.9MCall Options Held
81.6KPut Options Held
57.6K-
Black Rock Inc. New York, NY10.3MShares$103 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$97.8 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.84MShares$38.2 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$37.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.65MShares$36.4 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $1.35B
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...